Literature DB >> 25248907

[A case of locally advanced sigmoid colon cancer treated with neoadjuvant chemoradiotherapy].

Mami Yoshitomi1, Hiroki Hashida, Akinari Nomura, Shugo Ueda, Hiroaki Terajima, Nobuhiro Osaki.   

Abstract

The patient was a 38-year-old woman who visited our hospital complaining of nausea and abdominal pain. A colonoscopy revealed an advanced cancer in the sigmoid colon. A computed tomography (CT) scan showed left hydronephrosis and lymph node metastasis to the left iliopsoas muscle and left ureter. No distant metastasis was found. Since the surgical margins were likely to be positive with a one-stage resection, 3 cycles of FOLFOX4 (folinic acid, fluorouracil, and oxaliplatin)were administered after creating a transverse loop colostomy. Although the tumor decreased in size, the surgical margins were still suspected to be positive. For further regional tumor control, radiotherapy (1.8 Gy/day for 25 days) to the medial region of the left iliac bone and oral UFT/LV (uracil and tegafur/Leucovorin)were administered. A partial response(PR)was determined in accordance with the Response Evaluation Criteria in Solid Tumors(RECIST). Sigmoidectomy with partial resection of the left ureter was performed by laparotomy. The histologic response was assessed as Grade 2 and all surgical margins were negative. Preoperative chemoradiotherapy may be an effective therapeutic option for locally advanced colon cancer resistant to conventional preoperative chemotherapy.

Entities:  

Mesh:

Year:  2014        PMID: 25248907

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  6 in total

1.  Neoadjuvant Chemotherapy Improves Survival in Patients with Clinical T4b Colon Cancer.

Authors:  Ahmed Dehal; Amanda N Graff-Baker; Brooke Vuong; Trevan Fischer; Samuel J Klempner; Shu-Ching Chang; Gary L Grunkemeier; Anton J Bilchik; Melanie Goldfarb
Journal:  J Gastrointest Surg       Date:  2017-09-20       Impact factor: 3.452

2.  Treatment efficacy and prognosis analysis in locally advanced or metastatic colorectal cancer patients with hydronephrosis.

Authors:  Gangling Tong; Boran Chen; Mingying Zhang; Tianyu Wang; Xuan Wu; Yuye Yan; Shubin Wang; Shuluan Li
Journal:  Mol Clin Oncol       Date:  2022-04-20

3.  Efficacy of Neoadjuvant Chemotherapy with Capecitabine plus Oxaliplatin in the Treatment of Locally Advanced Sigmoid Colon Cancer Invading the Urinary Bladder: A Report of Three Cases.

Authors:  Tsutomu Takenami; Shingo Tsujinaka; Jun Takahashi; Sawako Tamaki; Ryo Maemoto; Rintaro Fukuda; Hideki Ishikawa; Nao Kakizawa; Fumi Hasegawa; Rina Kikugawa; Yasuyuki Miyakura; Koichi Suzuki; Akira Tanaka; Toshiki Rikiyama
Journal:  Case Rep Surg       Date:  2019-03-27

4.  Neoadjuvant chemoradiotherapy in patients with unresectable locally advanced sigmoid colon cancer: clinical feasibility and outcome.

Authors:  Shao-Qing Niu; Rong-Zhen Li; Yan Yuan; Wei-Hao Xie; Qiao-Xuan Wang; Hui Chang; Zhen-Hai Lu; Pei-Rong Ding; Li-Ren Li; Xiao-Jun Wu; Zhi-Fan Zeng; Wei-Wei Xiao; Yuan-Hong Gao
Journal:  Radiat Oncol       Date:  2021-05-24       Impact factor: 3.481

5.  Outcomes of preoperative chemoradiotherapy followed by surgery in patients with unresectable locally advanced sigmoid colon cancer.

Authors:  Bo Qiu; Pei-Rong Ding; Ling Cai; Wei-Wei Xiao; Zhi-Fan Zeng; Gong Chen; Zhen-Hai Lu; Li-Ren Li; Xiao-Jun Wu; Rene-Olivier Mirimanoff; Zhi-Zhong Pan; Rui-Hua Xu; Yuan-Hong Gao
Journal:  Chin J Cancer       Date:  2016-07-07

6.  Neoadjuvant chemoradiotherapy followed by surgery in patients with unresectable locally advanced colon cancer: a prospective observational study.

Authors:  Hui Chang; Xin Yu; Wei-Wei Xiao; Qiao-Xuan Wang; Wen-Hao Zhou; Zhi-Fan Zeng; Pei-Rong Ding; Li-Ren Li; Yuan-Hong Gao
Journal:  Onco Targets Ther       Date:  2018-01-17       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.